Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

1,630 public trials 214 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Completed

A Study of LY3023414 in Participants With Advanced Cancer

NCT01655225

Conditions
Adenoma, Advanced Cancer, Breast Diseases, +35 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Peggy and Charles Stephenson Oklahoma Cancer Center Oklahoma City, Oklahoma, United States
  • Penn Presbyterian Medical Center Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Trial of AB-205 in Adults With Lymphoma Undergoing High-Dose Therapy and Autologous Stem Cell Transplantation

NCT03925935

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +9 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • UC San Diego Moores Cancer Center San Diego, California, United States
  • The University of California San Francisco San Francisco, California, United States
View Trial Details
Completed

A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma

NCT01328626

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +17 more
Locations
  • University of Arizona Cancer Center - North Campus /ID# 52902 Tucson, Arizona, United States
  • Ucsd /Id# 48325 La Jolla, California, United States
  • Dana-Farber Cancer Institute /ID# 48324 Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center /ID# 56810 New York, United States
View Trial Details
Completed

Study to Evaluate the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic of CC-95775 in Subjects With Advanced Solid Tumors and Relapsed/Refractory Non-Hodgkin Lymphoma

NCT04089527

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations
  • Institut Curie Paris, France
  • Hopital Saint Louis Paris, France
  • Centre Eugene Marquis Rennes, France
  • Hospital de Madrid Norte- Sanchinarro Madrid, Spain
View Trial Details

Related conditions